全文获取类型
收费全文 | 625927篇 |
免费 | 53211篇 |
国内免费 | 21568篇 |
专业分类
耳鼻咽喉 | 6637篇 |
儿科学 | 15927篇 |
妇产科学 | 7436篇 |
基础医学 | 85681篇 |
口腔科学 | 15249篇 |
临床医学 | 58956篇 |
内科学 | 91748篇 |
皮肤病学 | 10623篇 |
神经病学 | 38367篇 |
特种医学 | 21701篇 |
外国民族医学 | 190篇 |
外科学 | 66646篇 |
综合类 | 81650篇 |
现状与发展 | 60篇 |
一般理论 | 27篇 |
预防医学 | 33401篇 |
眼科学 | 12497篇 |
药学 | 67140篇 |
193篇 | |
中国医学 | 28687篇 |
肿瘤学 | 57890篇 |
出版年
2023年 | 7686篇 |
2022年 | 11730篇 |
2021年 | 22840篇 |
2020年 | 19640篇 |
2019年 | 24574篇 |
2018年 | 19999篇 |
2017年 | 19963篇 |
2016年 | 21743篇 |
2015年 | 25444篇 |
2014年 | 41018篇 |
2013年 | 41711篇 |
2012年 | 40415篇 |
2011年 | 40505篇 |
2010年 | 35036篇 |
2009年 | 34341篇 |
2008年 | 33556篇 |
2007年 | 33865篇 |
2006年 | 29835篇 |
2005年 | 25132篇 |
2004年 | 19633篇 |
2003年 | 17329篇 |
2002年 | 13692篇 |
2001年 | 12293篇 |
2000年 | 10185篇 |
1999年 | 8727篇 |
1998年 | 7165篇 |
1997年 | 6742篇 |
1996年 | 6232篇 |
1995年 | 6465篇 |
1994年 | 5847篇 |
1993年 | 5040篇 |
1992年 | 4573篇 |
1991年 | 4159篇 |
1990年 | 3601篇 |
1989年 | 3366篇 |
1988年 | 3199篇 |
1987年 | 2714篇 |
1986年 | 2449篇 |
1985年 | 3852篇 |
1984年 | 3935篇 |
1983年 | 2796篇 |
1982年 | 3019篇 |
1981年 | 2726篇 |
1980年 | 2371篇 |
1979年 | 1949篇 |
1978年 | 1466篇 |
1977年 | 1335篇 |
1976年 | 1260篇 |
1975年 | 796篇 |
1974年 | 750篇 |
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
1.
Association of Multimodal Pain Control with Patient-Reported Outcomes in Children Undergoing Surgery
《Journal of pediatric surgery》2023,58(6):1206-1212
IntroductionOur aim was to describe practices in multimodal pain management at US children's hospitals and evaluate the association between non-opioid pain management strategies and pediatric patient-reported outcomes (PROs).MethodsData were collected as part of the 18-hospital ENhanced Recovery In CHildren Undergoing Surgery (ENRICH-US) clinical trial. Non-opioid pain management strategies included use of preoperative and postoperative non-opioid analgesics, regional anesthetic blocks, and a biobehavioral intervention. PROs included perioperative nervousness, pain-related functional disability, health-related quality of life (HRQoL). Associations were analyzed using multinomial logistic regression models.ResultsAmong 186 patients, 62 (33%) received preoperative analgesics, 186 (100%) postoperative analgesics, 81 (44%) regional anesthetic block, and 135 (73%) used a biobehavioral intervention. Patients were less likely to report worsened as compared to stable nervousness following regional anesthetic block (relative risk ratio [RRR]:0.31, 95% confidence interval [CI]:0.11–0.85), use of a biobehavioral technique (RRR:0.26, 95% CI:0.10–0.70), and both in combination (RRR:0.08, 95% CI:0.02–0.34). There were no associations of non-opioid pain control modalities with pain-related functional disability or HRQoL.ConclusionUse of postoperative non-opioid analgesics have been largely adopted, while preoperative non-opioid analgesics and regional anesthetic blocks are used less frequently. Regional anesthetic blocks and biobehavioral interventions may mitigate postoperative nervousness in children.Level of evidenceIII. 相似文献
2.
认知障碍是指记忆、语言、理解和判断等一个或多个方面的功能障碍,包括轻度认知障碍和各种类型的痴呆症。痴呆症是认知障碍最严重的表现,是一种导致患者日常生活、社会交往和工作能力发生显著变化的综合征。阿尔茨海默病(AD)是最常见的痴呆症类型,其次是血管性痴呆(VD)和其他神经退行性痴呆[1]。已知年龄与认知功能的退化密切相关。 相似文献
3.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
4.
5.
6.
7.
8.
《Vaccine》2022,40(30):4038-4045
PurposeAs protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion.MethodsA prospective observational study conducted in Maccabi Healthcare Services. Serial SARS-CoV-2 Spike IgG tests, 1,2,3 and 6 months following the second vaccine dose and one month following the third were obtained. Neutralizing antibody levels were measured in a subset of participants. Per individual SARS-CoV-2 Spike IgG titer ratios were calculated one month after the booster administration compared to titers one month following the second dose and prior to booster.ResultsAmong 110 participants, 56 (51%) were women. Mean age was 61.7 ± 1.9 years and 66 (60%) were immunocompromised. One month after third dose, IgG titers were induced 7.83 (95 %CI 5.25–11.67) folds and 2.40 (95 %CI 1.90–3.03) folds compared to one month after the second, in the immunocompromised and immunocompetent groups, respectively. Of the 17 immunocompromised participants who were seronegative after the second dose, 4 (24%) became seropositive following the third. Comparing the titers prior to the third dose, an increase of 50.7 (95 %CI 32.5–79.1) fold in the immunocompromised group and 25.7 (95 %CI 19.1–34.7) fold in and immunocompetent group, was observed.ConclusionA third BNT162b2 vaccine elicited robust humoral response, superior to the response observed following the second, among immunocompetent and immunocompromised individuals. 相似文献
9.
10.
目的探讨肺癌患者化疗后的癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)和鳞状上皮细胞癌抗原(SCC-Ag)表达变化。方法选取2017年5月至2020年2月间南京市六合区人民医院收治的100例肺癌患者,将这些患者作为肺癌组,另随机选取同期100例健康体检人员作为健康组。统计分析两组人员化疗前的血清NSE、CEA、SCC-Ag表达水平、肺癌组化疗成功患者化疗前后的血清NSE、CEA、SCC-Ag表达水平、肺癌组化疗失败患者化疗前后的血清NSE、CEA、SCC-Ag表达水平。结果肺癌组患者化疗前的血清NSE、CEA和SCC-Ag表达水平均高于健康组,差异均有统计学意义(均P <0.05)。肺癌组化疗成功患者化疗后的血清NSE、CEA和SCC-Ag表达水平均低于化疗前,均高于健康组,差异均有统计学意义(P <0.05)。肺癌组化疗失败患者化疗后的血清NSE、CEA、SCC-Ag表达水平均高于化疗前,均高于健康组,差异均有统计学意义(P <0.05)。结论对肺癌患者的NSE、CEA、SCC-Ag表达水平进行检测能够将化疗效果有效反映出来,进而有效指导临床的下一步治疗工作,从而有效改善患者预后。 相似文献